The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases

Int J Mol Sci. 2018 Dec 14;19(12):4058. doi: 10.3390/ijms19124058.

Abstract

Lipids and inflammation regulate each other. Early studies on this topic focused on the systemic effects that the acute inflammatory response-and interleukins-had on lipid metabolism. Today, in the era of the obesity epidemic, whose primary complications are cardio-metabolic diseases, attention has moved to the effects that the nutritional environment and lipid derangements have on peripheral tissues, where lipotoxicity leads to organ damage through an imbalance of chronic inflammatory responses. After an overview of the effects that acute inflammation has on the systemic lipid metabolism, this review will describe the lipid-induced immune responses that take place in peripheral tissues and lead to chronic cardio-metabolic diseases. Moreover, the anti-inflammatory effects of lipid lowering drugs, as well as the possibility of using anti-inflammatory agents against cardio-metabolic diseases, will be discussed.

Keywords: cholesterol; free fatty acids; innate immune system; interleukin; lipid; lipotoxicity; triglyceride.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / immunology
  • Cardiovascular Diseases / metabolism
  • Humans
  • Hypolipidemic Agents / pharmacology
  • Hypolipidemic Agents / therapeutic use
  • Immune System / drug effects
  • Immune System / metabolism
  • Inflammation / drug therapy
  • Inflammation / immunology
  • Inflammation / metabolism*
  • Interleukins / metabolism*
  • Lipid Metabolism / drug effects
  • Lipids / immunology*
  • Metabolic Diseases / drug therapy
  • Metabolic Diseases / immunology
  • Metabolic Diseases / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Hypolipidemic Agents
  • Interleukins
  • Lipids